Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $437.62 million. The enterprise value is $192.57 million.
Important Dates
The next estimated earnings date is Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 77.87 million shares outstanding. The number of shares has increased by 105.06% in one year.
| Current Share Class | 77.87M |
| Shares Outstanding | 77.87M |
| Shares Change (YoY) | +105.06% |
| Shares Change (QoQ) | +41.90% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 55.46% |
| Float | 37.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.34 |
| Quick Ratio | 8.98 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -550.26 |
Financial Efficiency
Return on equity (ROE) is -68.25% and return on invested capital (ROIC) is -39.21%.
| Return on Equity (ROE) | -68.25% |
| Return on Assets (ROA) | -36.35% |
| Return on Invested Capital (ROIC) | -39.21% |
| Return on Capital Employed (ROCE) | -56.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.54M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.18% in the last 52 weeks. The beta is 2.54, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.54 |
| 52-Week Price Change | -0.18% |
| 50-Day Moving Average | 5.72 |
| 200-Day Moving Average | 4.71 |
| Relative Strength Index (RSI) | 45.83 |
| Average Volume (20 Days) | 1,065,399 |
Short Selling Information
The latest short interest is 9.57 million, so 12.29% of the outstanding shares have been sold short.
| Short Interest | 9.57M |
| Short Previous Month | 10.18M |
| Short % of Shares Out | 12.29% |
| Short % of Float | 25.45% |
| Short Ratio (days to cover) | 7.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | -96.43M |
| Operating Income | -156.82M |
| Pretax Income | -154.08M |
| Net Income | -154.08M |
| EBITDA | -155.14M |
| EBIT | -156.82M |
| Earnings Per Share (EPS) | -$2.52 |
Full Income Statement Balance Sheet
The company has $268.11 million in cash and $23.05 million in debt, giving a net cash position of $245.06 million or $3.15 per share.
| Cash & Cash Equivalents | 268.11M |
| Total Debt | 23.05M |
| Net Cash | 245.06M |
| Net Cash Per Share | $3.15 |
| Equity (Book Value) | 258.29M |
| Book Value Per Share | 3.33 |
| Working Capital | 248.79M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$122.62 million and capital expenditures -$722,000, giving a free cash flow of -$123.34 million.
| Operating Cash Flow | -122.62M |
| Capital Expenditures | -722,000 |
| Free Cash Flow | -123.34M |
| FCF Per Share | -$1.58 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -105.06% |
| Shareholder Yield | -105.06% |
| Earnings Yield | -35.21% |
| FCF Yield | -28.18% |
Analyst Forecast
The average price target for SLDB is $15.00, which is 166.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 166.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -41.23% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |